---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-004842"
form_type: "8-K"
ticker: "NUTX"
cik: "0001479681"
company_name: "Nutex Health Inc."
filed_at: "2024-04-08T23:59:59+00:00"
generated_at: "2026-06-04T01:20:33.501738+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Nutex Health appoints Scott J. Saunders as independent director to fill vacancy

## Summary
- Scott J. Saunders, age 61, appointed to Board effective April 11, 2024, replacing deceased director John Waters.
- Board determined Saunders is independent under Nasdaq standards; term expires at 2024 Annual Meeting.
- Saunders receives standard non-employee director compensation: $150,000 per year in monthly installments.
- Saunders is Managing Director at Farlie Turner Gilbert, healthcare M&A advisor, with 30+ years in middle-market advisory.
- No family relationships or material interests between Saunders and company officers under Reg S-K Item 404(a).

## SEC filing metadata
- accession: 0001558370-24-004842
- form_type: 8-K
- ticker: NUTX
- cik: 0001479681
- company_name: Nutex Health Inc.
- filed_at: 2024-04-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1479681/000155837024004842/0001558370-24-004842-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1479681/000155837024004842/nutx-20240408x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-004842
- JSON: https://secwatch.observer/filing/0001558370-24-004842.json
- Plain text: https://secwatch.observer/filing/0001558370-24-004842.txt

## Key facts
- Executive change
  Scott J. Saunders was appointed as director at Nutex Health Inc..
  - Action: appointed
  - Role: director
  source text: appointed Scott J. Saunders, age 61, to serve as a director of the Company for a term commencing on April 11, 2024
  evidence_url: https://www.sec.gov/Archives/edgar/data/1479681/000155837024004842/0001558370-24-004842-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.